3,907 Shares in The Clorox Company (NYSE:CLX) Bought by Fiduciary Family Office LLC

Fiduciary Family Office LLC bought a new position in shares of The Clorox Company (NYSE:CLX) during the third quarter, Holdings Channel.com reports. The fund bought 3,907 shares of the company’s stock, valued at approximately $636,000.

A number of other institutional investors and hedge funds have also bought and sold shares of CLX. Mirae Asset Global Investments Co. Ltd. increased its position in Clorox by 99.8% during the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 45,813 shares of the company’s stock worth $7,136,000 after acquiring an additional 22,882 shares during the period. Tokio Marine Asset Management Co. Ltd. boosted its stake in shares of Clorox by 18.3% in the 1st quarter. Tokio Marine Asset Management Co. Ltd. now owns 3,748 shares of the company’s stock valued at $574,000 after purchasing an additional 581 shares in the last quarter. Fidelis Capital Partners LLC acquired a new stake in shares of Clorox in the 1st quarter valued at $63,000. Nordea Investment Management AB raised its holdings in shares of Clorox by 4.5% in the first quarter. Nordea Investment Management AB now owns 9,977 shares of the company’s stock valued at $1,519,000 after buying an additional 426 shares during the last quarter. Finally, Daiwa Securities Group Inc. raised its holdings in shares of Clorox by 44.2% in the first quarter. Daiwa Securities Group Inc. now owns 16,505 shares of the company’s stock valued at $2,527,000 after buying an additional 5,056 shares during the last quarter. Institutional investors own 78.53% of the company’s stock.

Analysts Set New Price Targets

CLX has been the subject of several recent research reports. Wells Fargo & Company dropped their price objective on Clorox from $135.00 to $130.00 and set an “underweight” rating for the company in a report on Wednesday, July 10th. Barclays upped their price target on Clorox from $137.00 to $139.00 and gave the company an “underweight” rating in a research note on Friday. TD Cowen initiated coverage on Clorox in a research note on Tuesday, July 23rd. They issued a “sell” rating and a $122.00 price target for the company. BNP Paribas raised Clorox to a “strong sell” rating in a research note on Friday, September 6th. Finally, Deutsche Bank Aktiengesellschaft upped their price target on Clorox from $144.00 to $151.00 and gave the company a “hold” rating in a research note on Friday, August 2nd. Six analysts have rated the stock with a sell rating, nine have given a hold rating and one has issued a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $151.57.

Insiders Place Their Bets

In other Clorox news, EVP Angela C. Hilt sold 1,733 shares of the stock in a transaction on Friday, September 6th. The stock was sold at an average price of $165.52, for a total transaction of $286,846.16. Following the transaction, the executive vice president now owns 13,471 shares in the company, valued at $2,229,719.92. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Company insiders own 0.57% of the company’s stock.

Clorox Stock Performance

CLX traded down $0.46 during trading hours on Tuesday, reaching $162.02. The company’s stock had a trading volume of 210,477 shares, compared to its average volume of 1,238,969. The Clorox Company has a 52 week low of $125.46 and a 52 week high of $169.09. The company’s 50-day moving average is $161.63 and its 200-day moving average is $146.33. The company has a debt-to-equity ratio of 11.08, a quick ratio of 0.62 and a current ratio of 1.00. The firm has a market cap of $20.05 billion, a PE ratio of 56.61, a price-to-earnings-growth ratio of 3.11 and a beta of 0.41.

Clorox (NYSE:CLX) last posted its quarterly earnings data on Wednesday, October 30th. The company reported $1.86 earnings per share for the quarter, topping the consensus estimate of $1.36 by $0.50. The firm had revenue of $1.76 billion for the quarter, compared to analysts’ expectations of $1.64 billion. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The company’s quarterly revenue was up 27.0% compared to the same quarter last year. During the same quarter last year, the business earned $0.49 EPS. On average, equities analysts forecast that The Clorox Company will post 6.81 EPS for the current year.

Clorox Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, November 7th. Shareholders of record on Wednesday, October 23rd will be given a dividend of $1.22 per share. This represents a $4.88 annualized dividend and a yield of 3.01%. The ex-dividend date of this dividend is Wednesday, October 23rd. Clorox’s payout ratio is 170.03%.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.